620524588 | PUO | 97359826 | | 7181693 | 6/17/2006 12:00:00 AM | S/P Lt THA | | DIS | Admission Date: 11/19/2006 Report Status:
Discharge Date: 2/25/2006
****** FINAL DISCHARGE ORDERS ******
SCHNEEKLOTH , LAVONNA 333-46-87-7
Ra Ce Room: Dilumra Dale Ster
Service: ORT
DISCHARGE PATIENT ON: 6/28/06 AT 11:00 AM
CONTINGENT UPON Cleared by PT
WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES
Attending: FANIEL , GAYLENE , M.D.
DISPOSITION: Home w/ services
DISCHARGE MEDICATIONS:
TYLENOL ( ACETAMINOPHEN ) 650 MG PO Q4H
Starting Today ( 5/29 ) PRN Pain
Instructions: Do not exceed 4000mg in 24 hours
BACLOFEN 20 MG PO QID
FIORICET ( BUTALBITAL+APAP+CAFFEINE ) 2 TAB PO Q6H
PRN Headache
Override Notice: Override added on 10/22/06 by
CASSA , MARITZA R. , M.D.
on order for COUMADIN PO ( ref # 701786646 )
POTENTIALLY SERIOUS INTERACTION: BUTALBITAL &amp; WARFARIN
POTENTIALLY SERIOUS INTERACTION: BUTALBITAL &amp; WARFARIN
Reason for override: qd inr Previous override information:
Override added on 7/26/06 by CASSA , MARITZA R. , M.D.
on order for COUMADIN PO 3 MG x1 ( ref # 620635771 )
POTENTIALLY SERIOUS INTERACTION: BUTALBITAL &amp; WARFARIN
POTENTIALLY SERIOUS INTERACTION: BUTALBITAL &amp; WARFARIN
Reason for override: wm Previous override information:
Override added on 5/4/06 by CASSA , MARITZA R. , M.D.
on order for COUMADIN PO 3 MG x1 ( ref # 996297324 )
POTENTIALLY SERIOUS INTERACTION: BUTALBITAL &amp; WARFARIN
POTENTIALLY SERIOUS INTERACTION: BUTALBITAL &amp; WARFARIN
Reason for override: wm Previous override information:
Override added on 5/27/06 by CASSA , MARITZA R. , M.D.
on order for COUMADIN PO 2 MG QPM ( ref # 916085073 )
POTENTIALLY SERIOUS INTERACTION: BUTALBITAL &amp; WARFARIN
POTENTIALLY SERIOUS INTERACTION: BUTALBITAL &amp; WARFARIN
Reason for override: wm Previous override information:
Override added on 5/27/06 by CASSA , MARITZA R. , M.D.
POTENTIALLY SERIOUS INTERACTION: WARFARIN &amp; BUTALBITAL
Reason for override: wm
COLACE ( DOCUSATE SODIUM ) 100 MG PO BID
FERROUS SULFATE 325 MG PO TID
Food/Drug Interaction Instruction Avoid milk and antacid
GLIPIZIDE XL 10 MG PO DAILY Starting IN AM ( 2/24 )
LISINOPRIL 5 MG PO DAILY
METFORMIN 1 , 000 MG PO BID
METHADONE 40 MG PO 5x daily Starting Today ( 5/29 )
Instructions: #70 40mg tablets dispensed
METHADONE 5 MG PO Q6H Starting Today ( 5/29 ) PRN Pain
Instructions: #60 5mg tablets dispensed
MVI ( MULTIVITAMINS ) 1 TAB PO DAILY
COUMADIN ( WARFARIN SODIUM ) 2.5 MG PO QPM
Starting ROUTINE , 20:00 ( Standard Admin Time )
Instructions: Or as directed by the Anticoagulation Service
Food/Drug Interaction Instruction
No high Vitamin-K containing foods
Alert overridden: Override added on 10/22/06 by
CASSA , MARITZA R. , M.D.
POTENTIALLY SERIOUS INTERACTION: BUTALBITAL &amp; WARFARIN
POTENTIALLY SERIOUS INTERACTION: BUTALBITAL &amp; WARFARIN
Reason for override: qd inr
DIET: No Restrictions
RETURN TO WORK: After Appt with local physician
FOLLOW UP APPOINTMENT( S ):
Dr Gaylene Faniel 6/8/06 Xray at 9:15am Appt at 10:15am 11/5/06 scheduled ,
Arrange INR to be drawn on 8/26/06 with f/u INR's to be drawn every
Mon/Thurs days. INR's will be followed by PUO Anticoagulation Service
ALLERGY: PROCHLORPERAZINE
ADMIT DIAGNOSIS:
Osteoarthritis Lt Hip
PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission )
S/P Lt THA
OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay
Legg-Calve-Perthes Disease , Diabetes Mellitus , Anemia , S/P
Parathyroidectomy , Migraine Headaches , H/O Cellulitis Lt Leg ,
Hypercalcemia
OPERATIONS AND PROCEDURES:
5/27/06 FANIEL , GAYLENE , M.D.
LT.TOTAL HIP REPLACWEMENT
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. )
Transfusion PRBC x 2 units
BRIEF RESUME OF HOSPITAL COURSE:
Patient has hx of Legg-Calve-Perthes disease s/p chiari osteotomy
complicated by septic arthritis x 2. Recent radiographic studies
revealed end stage osteoarthritis of L hip with cystic changes noted in
femoral head. Pt was taken to the OR on 9/22/06 for Lt total hip
replacement. The patient tolerated the procedure well , and there were no
complications. Routine peri-op IV antibiotics were given. Acute pain
management with PCA until POD2 , when the patient transitioned to PO pain
medications. Patient steadily with daily physical therapy. Patient was
made PWB ( 50% ) on LLE with functional abduction only , and posterior hip
dislocation precautions. The dressing was changed on POD2 and on discharge
the incision was clean/dry/intact with no erythema. HCT was noted to be 23
on POD#1 and patient received transfusion of 2 units PRBC. Upon discharge ,
the patient was afebrile with stable vital signs and intact neurovascular
status in the operative extremity. Coumadin/TEDs/pneumoboots for DVT
prophylaxis. INR was 2.0 on the day of discharge and should receive 2.5
mg of coumadin on the evening of discharge.
ADDITIONAL COMMENTS: Call or return to ER for fever &gt;101.5 , increased redness , swelling or
discharge from incision , chest pain , shortness of breath , or anything
else that is troubling you. OK to shower but do not soak incision in
tub/pools/etc. for at least two weeks. Partial weight bearing ( 50% ) LLE ,
functional abduction as per PT page 3 until cleared at follow-up.
Posterior hip dislocation precautions. Do not drive or drink alcohol
while taking narcotic pain medications. Resume all home medications.
Follow-up as scheduled with surgeon. Follow-up with your primary care
physician within one month for reassessment of home medications post
surgery. Coumadin x 4 weeks. Goal INR 1.5-2.5. Please call or fax
results to PUO anticoagulation service at 689-1096 f1 . Blood draws for
PT/INR the day after discharge , then every Mon/Thurs. Any outpatient
anticoagulation issues , or action values should be called to the
Anticoagulation Service. Suture removal as of 2/4/06 , by VNA. Contact
your primary care physician for pain medication renewals.
DISCHARGE CONDITION: Stable
TO DO/PLAN:
Blood draws for PT/INR the day after discharge , then q Mon/Thurs with
results called to 765-060-3001 jys 9 for outpatient
anticoagulation management
Suture Removal 2/4/06
Home services for nursing/wound assessment , PT , &amp; phlebotomy
Follow up w/ Dr Aspen as scheduled
Contact your primary care physician for medication refills
No dictated summary
ENTERED BY: SCOVEL , DULCIE , PA-C ( XP60 ) 6/28/06 @ 07
****** END OF DISCHARGE ORDERS ******